Display Options:
Total: 968
Antibody
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders
Transferrin receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Neuropilin-1 inhibitor
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Cell surface A33 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Hematologic Neoplasms
G-protein coupled receptor family C group 5 member D binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Epstein-Barr Virus Infections; Neuroblastoma
Disialoganglioside GD2 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Mesothelin binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Selectin E inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Placenta growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist
Antibody
Investigational
Unknown
Unknown
Arthritis, Psoriatic
Interleukin 17A inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Tumor necrosis factor receptor superfamily member 8 binding agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Histiocytoma, Malignant Fibrous
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Bone Diseases, Metabolic
Sclerostin inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell
CD70 antigen cross-linking agent
Antibody
Investigational
Unknown
Unknown
Unknown
B-lymphocyte antigen CD19 binding agent
Antibody
Investigational
Unknown
Unknown
Adenocarcinoma
Carcinoembryonic antigen-related cell adhesion molecule 5 cross-linking agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplasms
CD44 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Staphylococcal Infections
Unknown
Antibody
Investigational
Unknown
Unknown
Anemia
Hepcidin inhibitor
Antibody
Investigational
Unknown
Unknown
Influenza, Human
Tumor susceptibility gene 101 protein inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Integrin beta-2 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown